Early Experiences with a Novel New BotulinumtoxinA Product
Steven Fagien, MD, FACS – Moderator
Steven Fagien, MD, FACS Aesthetic Eyelid Plastic Surgery
Boca Raton, FL
Jody Comstock, MD
Sue Ellen Cox, MD
Chapel Hill, NC
Jeffrey Steven Dover, MD
Chestnut Hill, MA
Rebecca L. Fitzgerald, MD
Rebecca Fitzgerald MD Dermatology
Los Angeles, CA
Michael A.C. Kane, MD
Kane Plastic Surgery
New York, NY
Ruth Tedaldi, MD
Dermatology Partners, Inc.
DaxibotulinumtoxinA, the newest addition to the US BoNTA market, is a new formulation and to assist clinicians gain familiarity and confidence in using the product, this activity has been developed. Included is a lecture outlining different BoNTA formulations, mechanisms of action, potential differences, as well as clinical results. Patient demonstrations are included as well as edited video segments from a Faculty Roundtable held in Nov. 2022.To complete this activity and receive credit, the participant should:
- Review the materials on accreditation information, target audience, learning objectives, and disclosure information
- Complete the entire self-study
- Complete the post-test and evaluation/claim form
Jointly Provided by:
Upon completion of this program, participants should be able to:
- Discuss the basic science of BoNTA products currently approved in the US.
- Understand the proposed mechanism of action for DaxibotulinumtoxinA, thought to underpin the observed longevity in clinical trials.
- Discuss clinical differentiation of BoNTA products.
- Describe any differences in injection techniques for DaxibotulinumtoxinA that have been adopted in clinical practice.
Commercial Support Acknowledgement
Support for this educational activity is provided by Revance Therapeutics.
This CME-certified activity is primarily intended and designed to educate clinicians who inject botulinumtoxin products.
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and xMedica, LLC. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medical Education Resources designates this enduring activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Academy of Nurse Practitioners (AANP)
The American Academy of Nurse Practitioners (AANP) Certification Board recognizes and accepts continuing education (CE) 2.25 contact hours from activities approved by AMA, ACCME, ANCC, AANP, AAFP and AACN.
Medical Education Resources designates this enduring activity for a maximum of 2.25 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 2.25 contact hours.
Physician Assistant Credit
Medical Education Resources has been authorized by the American Academy of Physician Assistants (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.25 AAPA Category 1 CME Credits. Physician Assistants should only claim credit commensurate with the extent of their participation.
Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
Method of Participation
There are no fees for participating in and receiving credit for this activity. During the period January 2023 through January 2025, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by recording the best answer to each question, and 4) complete the evaluation form.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 80% or better. Statements of credit will be issued at the end of the program.
Medical Education Resources
Medical Education Resources and xMedica maintain high standards for the protection of privacy over the Internet. The purpose of this statement is to explain what information we obtain, how it is used, and how visitors can restrict its use or disclosure.
The only information MER obtains is information supplied voluntarily by the visitor.
We do not sell or disclose individually identifiable information obtained online unless it is required by law or disclosure is necessary to protect the safety of customers, employees, or property.
We use the information to grade your posttest and to send you a certificate of completion of the activity. If we use a third-party company to grade your posttest and issue certificates of completion, we will give the information to that company for that purpose only.
For each activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
We may use the information to invite you to participate in other activities that we may offer.
The website is supported by the latest versions of most modern web browsers. In order to experience the website fully, please upgrade to the latest version of one of the following browsers:
- Google Chrome (recommended)
- Microsoft Edge
- Mozilla Firefox
- Apple Safari
- Apple Mobile Safari
Connection Speed Requirements
DSL or faster